Executive Summary
According to GRD Survey data, the global Melanotan II market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Melanotan II market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Melanotan II in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Purity from 95% to 98%
Purity above 98%
Market Snapshot, By Application
Nutritional Supplement
Bodybuilders
Skin Tanning
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
PolyPeptide Labs
Phoenix Pharmaceuticals Inc.
PeptiDream
Chinese Peptide Company
Biocom California
Bachem
AmbioPharm
Aapptec
The study objectives of this report are:
To study and analyze the global Melanotan II market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Melanotan II market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Melanotan II manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Melanotan II market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Melanotan II submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Melanotan II are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Melanotan II Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Melanotan II Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Melanotan II
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Melanotan II Sales Channel and Distributors Analysis
3.3.1 Melanotan II Sales Channel
3.3.2 Melanotan II Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Melanotan II Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Melanotan II Type Introduction
4.1.1 Purity from 95% to 98%
4.1.2 Purity above 98%
4.2 Global Melanotan II Sales by Type 2016-2021
4.3 Global Melanotan II Revenue by Type 2016-2021
4.4 Global Melanotan II Price by Type 2016-2021
5 Market Segment: by Application
5.1 Melanotan II Type Introduction
5.1.1 Nutritional Supplement
5.1.2 Bodybuilders
5.1.3 Skin Tanning
5.2 Global Melanotan II Sales by Application 2016-2021
5.3 Global Melanotan II Revenue by Application 2016-2021
5.4 Global Melanotan II Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Melanotan II Market by Region
6.1.1 Global Melanotan II Sales by Regions
6.1.2 Global Melanotan II Revenue by Regions
6.2 North America Melanotan II Market 2016-2021
6.3 Europe Melanotan II Market 2016-2021
6.4 Asia Pacific Melanotan II Market 2016-2021
6.5 South America Melanotan II Market 2016-2021
6.6 Middle East and Africa Melanotan II Market 2016-2021
7 North America
7.1 North America Melanotan II Market by Country 2016-2021
7.1.1 North America Melanotan II Sales by Country
7.1.2 North America Melanotan II Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Melanotan II Market by Country 2016-2021
8.1.1 Europe Melanotan II Sales by Country
8.1.2 Europe Melanotan II Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Melanotan II Market by Country 2016-2021
9.1.1 Asia Pacific Melanotan II Sales by Country
9.1.2 Asia Pacific Melanotan II Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Melanotan II Market by Country 2016-2021
10.1.1 South America Melanotan II Sales by Country
10.1.2 South America Melanotan II Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Melanotan II Market by Country 2016-2021
11.1.1 Middle East and Africa Melanotan II Sales by Country
11.1.2 Middle East and Africa Melanotan II Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 PolyPeptide Labs
12.1.1 PolyPeptide Labs Company Information
12.1.2 PolyPeptide Labs Melanotan II Product Portfolio, Specification and Application
12.1.3 PolyPeptide Labs Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 PolyPeptide Labs Key Development
12.2 Phoenix Pharmaceuticals Inc.
12.2.1 Phoenix Pharmaceuticals Inc. Company Information
12.2.2 Phoenix Pharmaceuticals Inc. Melanotan II Product Portfolio, Specification and Application
12.2.3 Phoenix Pharmaceuticals Inc. Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Phoenix Pharmaceuticals Inc. Key Development
12.3 PeptiDream
12.3.1 PeptiDream Company Information
12.3.2 PeptiDream Melanotan II Product Portfolio, Specification and Application
12.3.3 PeptiDream Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 PeptiDream Key Development
12.4 Chinese Peptide Company
12.4.1 Chinese Peptide Company Company Information
12.4.2 Chinese Peptide Company Melanotan II Product Portfolio, Specification and Application
12.4.3 Chinese Peptide Company Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Chinese Peptide Company Key Development
12.5 Biocom California
12.5.1 Biocom California Company Information
12.5.2 Biocom California Melanotan II Product Portfolio, Specification and Application
12.5.3 Biocom California Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Biocom California Key Development
12.6 Bachem
12.6.1 Bachem Company Information
12.6.2 Bachem Melanotan II Product Portfolio, Specification and Application
12.6.3 Bachem Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Bachem Key Development
12.7 AmbioPharm
12.7.1 AmbioPharm Company Information
12.7.2 AmbioPharm Melanotan II Product Portfolio, Specification and Application
12.7.3 AmbioPharm Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Bachem Key Development
12.8.1 Aapptec Company Information
12.8.2 Aapptec Melanotan II Product Portfolio, Specification and Application
12.8.3 Aapptec Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Aapptec Key Development
13 Global Melanotan II Market Forecast by Region by Type and by Application
13.1 Global Melanotan II Sales, Revenue Forecast 2022-2027
13.2 Global Melanotan II Forecast by Regions
13.2.1 Global Melanotan II Sales Forecast by Region 2022-2027
13.2.2 Global Melanotan II Revenue Forecast by Region 2022-2027
13.3 Global Melanotan II Forecast by Type
13.3.1 Global Melanotan II Sales Forecast by Type 2022-2027
13.3.2 Global Melanotan II Revenue Forecast by Type 2022-2027
13.3.3 Global Melanotan II Price Forecast by Type 2022-2027
13.4 Global Melanotan II Forecast by Application
13.4.1 Global Melanotan II Sales Forecast by Application 2022-2027
13.4.2 Global Melanotan II Revenue Forecast by Application 2022-2027
13.4.3 Global Melanotan II Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Melanotan II Production Specifications
Table 2: Drivers in Melanotan II Market
Table 3: Restraints Melanotan II Market
Table 4: Opportunity in Melanotan II Market
Table 5: Comparion of Alternative and Melanotan II
Table 6: Melanotan II Raw Materials Key Suppliers List
Table 7: Melanotan II Distributors List
Table 8: Melanotan II Major Buyers in Application One
Table 9: Melanotan II Major Buyers in Application Two
Table 10: Melanotan II Major Buyers in Application Three
Table 11: Global Melanotan II Sales (K Units) by Type 2016-2021
Table 12: Global Melanotan II Sales Market Share by Type 2016-2021
Table 13: Global Melanotan II Revenue (Million USD) by Type 2016-2021
Table 14: Global Melanotan II Revenue Market Share by Type 2016-2021
Table 15: Global Melanotan II Price by Type 2016-2021
Table 16: Global Melanotan II Sales (K Units) by Application 2016-2021
Table 17: Global Melanotan II Sales Market Share by Application 2016-2021
Table 18: Global Melanotan II Revenue (Million USD) by Application 2016-2021
Table 19: Global Melanotan II Revenue Market Share by Application 2016-2021
Table 20: Global Melanotan II Price by Application 2016-2021
Table 21: Global Melanotan II Sales (K Units) by Region 2016-2021
Table 22: Global Melanotan II Sales Market Share by Region 2016-2021
Table 23: Global Melanotan II Revenue (Million USD) by Region 2016-2021
Table 24: Global Melanotan II Revenue Market Share by Region 2016-2021
Table 25: North America Melanotan II Sales (K Units) by Country 2016-2021
Table 26: North America Melanotan II Sales Market Share by Country 2016-2021
Table 27: North America Melanotan II Revenue (Million USD) by Country 2016-2021
Table 28: North America Melanotan II Revenue Market Share by Country 2016-2021)
Table 29: Europe Melanotan II Sales (K Units) by Country 2016-2021
Table 30: Europe Melanotan II Sales Market Share by Country 2016-2021
Table 31: Europe Melanotan II Revenue (Million USD) by Country 2016-2021
Table 32: Europe Melanotan II Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Melanotan II Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Melanotan II Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Melanotan II Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Melanotan II Revenue Market Share by Country 2016-2021)
Table 37: South America Melanotan II Sales (K Units) by Country 2016-2021
Table 38: South America Melanotan II Sales Market Share by Country 2016-2021
Table 39: South America Melanotan II Revenue (Million USD) by Country 2016-2021
Table 40: South America Melanotan II Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Melanotan II Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Melanotan II Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Melanotan II Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Melanotan II Revenue Market Share by Country 2016-2021)
Table 45 PolyPeptide Labs Company Information
Table 46 PolyPeptide Labs Melanotan II Product Portfolio, Specification and Application
Table 47 PolyPeptide Labs Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Phoenix Pharmaceuticals Inc. Company Information
Table 49 Phoenix Pharmaceuticals Inc. Melanotan II Product Portfolio, Specification and Application
Table 50 Phoenix Pharmaceuticals Inc. Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 PeptiDream Company Information
Table 52 PeptiDream Melanotan II Product Portfolio, Specification and Application
Table 53 PeptiDream Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Chinese Peptide Company Company Information
Table 55 Chinese Peptide Company Melanotan II Product Portfolio, Specification and Application
Table 56 Chinese Peptide Company Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Biocom California Company Information
Table 58 Biocom California Melanotan II Product Portfolio, Specification and Application
Table 59 Biocom California Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Bachem Company Information
Table 61 Bachem Melanotan II Product Portfolio, Specification and Application
Table 62 Bachem Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 AmbioPharm Company Information
Table 64 AmbioPharm Melanotan II Product Portfolio, Specification and Application
Table 65 AmbioPharm Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Aapptec Company Information
Table 67 Aapptec Melanotan II Product Portfolio, Specification and Application
Table 68 Aapptec Melanotan II Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Melanotan II Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Melanotan II Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Melanotan II Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Melanotan II Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Melanotan II Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Melanotan II Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Melanotan II Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Melanotan II Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Melanotan II Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Melanotan II Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Melanotan II Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Melanotan II Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Melanotan II Picture
Figure 2: Global Melanotan II Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Melanotan II Supply Chain Analysis
Figure 5: Melanotan II Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Purity from 95% to 98%
Figure 7: Product Picture of Purity above 98%
Figure 8: Global Melanotan II Sales Market Share by Type, 2020
Figure 9: Global Melanotan II Revenue Market Share by Type, 2020
Figure 10: Melanotan II in Nutritional Supplement
Figure 11: Global Melanotan II Market: Nutritional Supplement 2016-2021
Figure 12: Melanotan II in Bodybuilders
Figure 13: Global Melanotan II Market: Bodybuilders 2016-2021
Figure 14: Global Melanotan II Sales Market Share by Application, 2020
Figure 15: Global Melanotan II Revenue Market Share by Application, 2020
Figure 16: Global Melanotan II Sales Market Share by Region 2016-2021
Figure 17: Global Melanotan II Revenue Market Share by Region 2016-2021
Figure 18: North America Melanotan II Sales (K Units) Status 2016-2021
Figure 19: North America Melanotan II Revenue (Million USD) Status 2016-2021
Figure 20: Europe Melanotan II Sales (K Units) Status 2016-2021
Figure 21: Europe Melanotan II Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Melanotan II Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Melanotan II Revenue (Million USD) Status 2016-2021
Figure 24: South America Melanotan II Sales (K Units) Status 2016-2021
Figure 25: South America Melanotan II Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Melanotan II Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Melanotan II Revenue (Million USD) Status 2016-2021
Figure 28: North America Melanotan II Sales Market Share by Country, 2020
Figure 29: North America Melanotan II Revenue Market Share by Country, 2020
Figure 30: United States Melanotan II Sales (K Units) Status 2016-2021
Figure 31: United States Melanotan II Revenue (Million USD) Status 2016-2021
Figure 32: Canada Melanotan II Sales (K Units) Status 2016-2021
Figure 33: Canada Melanotan II Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Melanotan II Sales (K Units) Status 2016-2021
Figure 35: Mexico Melanotan II Revenue (Million USD) Status 2016-2021
Figure 36: Europe Melanotan II Sales Market Share by Country, 2020
Figure 37: Europe Melanotan II Revenue Market Share by Country, 2020
Figure 38: Germany Melanotan II Sales (K Units) Status 2016-2021
Figure 39: Germany Melanotan II Revenue (Million USD) Status 2016-2021
Figure 40: France Melanotan II Sales (K Units) Status 2016-2021
Figure 41: France Melanotan II Revenue (Million USD) Status 2016-2021
Figure 42: UK Melanotan II Sales (K Units) Status 2016-2021
Figure 43: UK Melanotan II Revenue (Million USD) Status 2016-2021
Figure 44: Italy Melanotan II Sales (K Units) Status 2016-2021
Figure 45: Italy Melanotan II Revenue (Million USD) Status 2016-2021
Figure 46: Russia Melanotan II Sales (K Units) Status 2016-2021
Figure 46: Russia Melanotan II Revenue (Million USD) Status 2016-2021
Figure 47: Spain Melanotan II Sales (K Units) Status 2016-2021
Figure 48: Spain Melanotan II Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Melanotan II Sales Market Share by Country, 2020
Figure 50: Asia Pacific Melanotan II Revenue Market Share by Country, 2020
Figure 51: China Melanotan II Sales (K Units) Status 2016-2021
Figure 52: China Melanotan II Revenue (Million USD) Status 2016-2021
Figure 53: Japan Melanotan II Sales (K Units) Status 2016-2021
Figure 54: Japan Melanotan II Revenue (Million USD) Status 2016-2021
Figure 55: Korea Melanotan II Sales (K Units) Status 2016-2021
Figure 56: Korea Melanotan II Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Melanotan II Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Melanotan II Revenue (Million USD) Status 2016-2021
Figure 59: India Melanotan II Sales (K Units) Status 2016-2021
Figure 60: India Melanotan II Revenue (Million USD) Status 2016-2021
Figure 61: Australia Melanotan II Sales (K Units) Status 2016-2021
Figure 62: Australia Melanotan II Revenue (Million USD) Status 2016-2021
Figure 63: South America Melanotan II Sales Market Share by Country, 2020
Figure 64: South America Melanotan II Revenue Market Share by Country, 2020
Figure 65: Brazil Melanotan II Sales (K Units) Status 2016-2021
Figure 66: Brazil Melanotan II Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Melanotan II Sales (K Units) Status 2016-2021
Figure 68: Argentina Melanotan II Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Melanotan II Sales (K Units) Status 2016-2021
Figure 70: Colombia Melanotan II Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Melanotan II Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Melanotan II Revenue Market Share by Country, 2020
Figure 73: Turkey Melanotan II Sales (K Units) Status 2016-2021
Figure 74: Turkey Melanotan II Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Melanotan II Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Melanotan II Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Melanotan II Sales (K Units) Status 2016-2021
Figure 78: South Africa Melanotan II Revenue (Million USD) Status 2016-2021
Figure 79: PolyPeptide Labs Melanotan II Revenue Market Share Globally (2019-2021)
Figure 80: Phoenix Pharmaceuticals Inc. Melanotan II Revenue Market Share Globally (2019-2021)
Figure 81: PeptiDream Melanotan II Revenue Market Share Globally (2019-2021)
Figure 82: Chinese Peptide Company Melanotan II Revenue Market Share Globally (2019-2021)
Figure 83: Biocom California Melanotan II Revenue Market Share Globally (2019-2021)
Figure 84: Bachem Melanotan II Revenue Market Share Globally (2019-2021)
Figure 85: AmbioPharm Melanotan II Revenue Market Share Globally (2019-2021)
Figure 86: Aapptec Melanotan II Revenue Market Share Globally (2019-2021)
Figure 89: Global Melanotan II Sales (K Units) Forecast (2022-2027)
Figure 90: Global Melanotan II Sales (K Units) Forecast (2022-2027)
Reason to Buy